JP2021502964A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021502964A5 JP2021502964A5 JP2020526214A JP2020526214A JP2021502964A5 JP 2021502964 A5 JP2021502964 A5 JP 2021502964A5 JP 2020526214 A JP2020526214 A JP 2020526214A JP 2020526214 A JP2020526214 A JP 2020526214A JP 2021502964 A5 JP2021502964 A5 JP 2021502964A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- strain
- pharmaceutical composition
- interleukin
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762585782P | 2017-11-14 | 2017-11-14 | |
| US62/585,782 | 2017-11-14 | ||
| PCT/US2018/060998 WO2019099482A1 (en) | 2017-11-14 | 2018-11-14 | Compositions and methods for treating disease using a blautia strain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021502964A JP2021502964A (ja) | 2021-02-04 |
| JP2021502964A5 true JP2021502964A5 (enExample) | 2021-12-23 |
Family
ID=64746632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020526214A Pending JP2021502964A (ja) | 2017-11-14 | 2018-11-14 | ブラウティア（Ｂｌａｕｔｉａ）株を使用して疾患を処置するための組成物及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10493113B2 (enExample) |
| EP (1) | EP3710023A1 (enExample) |
| JP (1) | JP2021502964A (enExample) |
| CN (1) | CN111601610A (enExample) |
| AR (1) | AR113881A1 (enExample) |
| TW (1) | TW201936203A (enExample) |
| WO (1) | WO2019099482A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL265109B2 (en) | 2016-09-13 | 2024-05-01 | Allergan Inc | Stabilized non-protein clostridial toxin compositions |
| CN116196425A (zh) | 2016-09-27 | 2023-06-02 | 得克萨斯系统大学评议会 | 通过调节微生物组来增强免疫检查点阻断疗法的方法 |
| US11241461B2 (en) * | 2017-08-29 | 2022-02-08 | Evelo Biosciences, Inc. | Treating cancer using a blautia strain |
| US10493113B2 (en) | 2017-11-14 | 2019-12-03 | Evelo Biosciences, Inc. | Compositions and methods for treating disease using a Blautia strain |
| EP3746121A1 (en) * | 2018-01-31 | 2020-12-09 | Evelo Biosciences, Inc. | Compositions and methods for treating immune disorders using lachnospiraceae bacteria |
| JP7340591B2 (ja) * | 2018-07-11 | 2023-09-07 | アクティム・セラピューティクス・インコーポレイテッド | 遺伝子操作された免疫刺激性細菌菌株およびその使用 |
| CA3120709A1 (en) | 2018-11-21 | 2020-05-28 | Board Of Regents, The University Of Texas System | Methods and compositions for treating cancer |
| US20220080001A1 (en) * | 2019-01-16 | 2022-03-17 | Board Of Regents, The University Of Texas System | Methods and compositions for treating immune checkpoint inhibitor associated colitis |
| MX2021013776A (es) * | 2019-05-10 | 2021-12-10 | 4D Pharma Res Limited | Composiciones que comprenden cepas bacterianas. |
| WO2020252144A1 (en) * | 2019-06-11 | 2020-12-17 | Evelo Biosciences, Inc. | Secreted microbial extracellular vesicles |
| CN112442455B (zh) * | 2019-09-03 | 2022-04-01 | 北京量化健康科技有限公司 | 具有防治高血脂症功能的布劳特氏菌以及产品组合物及其制备方法和应用 |
| CN111304120B (zh) * | 2020-02-24 | 2021-07-23 | 浙江大学 | Blautia sp B2132菌在预防和/或治疗炎症性肠病中的应用 |
| AU2021280299B2 (en) | 2020-05-28 | 2025-08-21 | Trench Therapeutics, Inc. | Airway medicaments |
| AR122610A1 (es) * | 2020-06-11 | 2022-09-21 | Evelo Biosciences Inc | Composiciones y métodos para el tratamiento de enfermedades y trastornos usando vesículas extracelulares microbianas de oscillospiraceae |
| WO2021252861A1 (en) * | 2020-06-11 | 2021-12-16 | Evelo Biosciences, Inc. | Compositions and methods for treating diseases and disorders using megasphaera sp |
| CN115768448A (zh) * | 2020-06-11 | 2023-03-07 | 伊夫罗生物科学公司 | 使用马西里福涅拉氏菌治疗疾病和障碍的组合物和方法 |
| CN113842497B (zh) * | 2021-09-28 | 2022-05-17 | 太原理工大学 | 一种具有光控抗菌和自愈合功能的CuS@Cur杂化水凝胶敷料的制备方法 |
| CN114225024B (zh) * | 2021-12-29 | 2022-08-19 | 山东健袖生态科技有限公司 | 一种用于治疗疾病的益生菌药物 |
| EP4494484A4 (en) | 2022-03-18 | 2026-03-18 | Meiji Co Ltd | COMPOSITION FOR CONTROLLING THE PROLIFERATION OF COLLINSELLA BACTERIA AND ITS USE |
| WO2023192360A1 (en) * | 2022-03-31 | 2023-10-05 | Incelldx, Inc. | Methods of treating a subject for post-treatment lyme disease (ptld) and compositions for use in the same |
| US20250235433A1 (en) * | 2022-04-19 | 2025-07-24 | Cedars-Sinai Medical Center | Methods of treating and diagnosing fatty liver disease |
| CN114806979A (zh) * | 2022-06-29 | 2022-07-29 | 杭州师范大学附属医院(杭州市第二人民医院) | 一种治疗非酒精性脂肪性肝病的益生菌复合物及其应用 |
| CN116254198B (zh) * | 2023-01-05 | 2024-03-26 | 中国科学院微生物研究所 | 一种布劳特氏菌及其应用 |
| CN116549465B (zh) * | 2023-04-26 | 2025-02-11 | 复旦大学附属中山医院 | Aldh2小分子激动剂在制备治疗心血管疾病及其代谢性疾病的药物中的应用 |
| JP7706190B2 (ja) * | 2023-09-25 | 2025-07-11 | オルト株式会社 | ブラウティア属細菌 |
| WO2025070280A1 (ja) * | 2023-09-25 | 2025-04-03 | オルト株式会社 | ブラウティア属細菌 |
| WO2025070283A1 (ja) * | 2023-09-25 | 2025-04-03 | オルト株式会社 | ブラウティア属細菌を用いた免疫賦活剤 |
| JP7706191B2 (ja) * | 2023-09-25 | 2025-07-11 | オルト株式会社 | ブラウティア属細菌を用いた免疫賦活剤 |
| CN117617181B (zh) * | 2023-12-27 | 2025-10-28 | 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) | 一种系统性红斑狼疮小鼠模型的构建方法和应用 |
| CN119709558B (zh) * | 2025-02-26 | 2025-05-30 | 昆明医科大学第一附属医院(云南省皮肤病医院) | 布劳特氏菌emf75-02b1b及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6368586B1 (en) | 1996-01-26 | 2002-04-09 | Brown University Research Foundation | Methods and compositions for enhancing the bioadhesive properties of polymers |
| AU2014239883B2 (en) | 2013-03-14 | 2019-01-17 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
| WO2014201037A2 (en) * | 2013-06-10 | 2014-12-18 | New York University | Methods for manipulating immune responses by altering microbiota |
| AU2015353465B2 (en) * | 2014-11-25 | 2021-07-29 | Memorial Sloan-Kettering Cancer Center | Intestinal microbiota and GVHD |
| MA41020A (fr) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| US9492473B2 (en) * | 2015-01-26 | 2016-11-15 | Kaleido Biosciences, Inc. | Glycan therapeutics and related methods thereof |
| EP3964234A1 (en) * | 2015-04-23 | 2022-03-09 | Kaleido Biosciences, Inc. | Glycan therapeutics and methods of treatment |
| SI3240554T1 (sl) * | 2015-06-15 | 2019-12-31 | 4D Pharma Research Limited, | Blautia stercosis in wexlerae za uporabo v zdravljenju vnetnih in avtoimunskih bolezni |
| HK1258531A1 (zh) * | 2015-08-24 | 2019-11-15 | 努比约塔有限公司 | 使用粪源细菌群落来治疗微生态失衡的系统和方法 |
| CN107083339B (zh) * | 2017-03-01 | 2020-02-14 | 华中农业大学 | 防治仔猪腹泻的复合益生菌制剂及其制备方法和应用 |
| US10493113B2 (en) * | 2017-11-14 | 2019-12-03 | Evelo Biosciences, Inc. | Compositions and methods for treating disease using a Blautia strain |
-
2018
- 2018-11-14 US US16/190,735 patent/US10493113B2/en active Active
- 2018-11-14 TW TW107140449A patent/TW201936203A/zh unknown
- 2018-11-14 AR ARP180103328A patent/AR113881A1/es unknown
- 2018-11-14 CN CN201880073533.9A patent/CN111601610A/zh active Pending
- 2018-11-14 JP JP2020526214A patent/JP2021502964A/ja active Pending
- 2018-11-14 EP EP18822542.9A patent/EP3710023A1/en not_active Withdrawn
- 2018-11-14 WO PCT/US2018/060998 patent/WO2019099482A1/en not_active Ceased
-
2019
- 2019-10-07 US US16/595,085 patent/US10702561B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021512133A5 (enExample) | ||
| JP2020526581A5 (enExample) | ||
| JP7305704B2 (ja) | Ｔ細胞療法のための診断方法 | |
| JP7238030B2 (ja) | Ｔ細胞療法のために患者をコンディショニングする方法 | |
| CA3068757A1 (en) | Compositions and methods of treating cancer using bifidobacterium animalis ssp. lactis | |
| US20240374728A1 (en) | T Cell Modification | |
| JP2021502964A (ja) | ブラウティア（Ｂｌａｕｔｉａ）株を使用して疾患を処置するための組成物及び方法 | |
| JP2021512133A (ja) | ベイロネラ（Ｖｅｉｌｌｏｎｅｌｌａ）の細菌を使用して癌及び免疫障害を処置するための組成物及び方法 | |
| JP2020533291A (ja) | プレボテラ（Ｐｒｅｖｏｔｅｌｌａ）由来の細胞外小胞 | |
| JP2021512106A (ja) | ラクノスピラ科（Ｌａｃｈｎｏｓｐｉｒａｃｅａｅ）の細菌を使用して免疫障害を処置するための組成物及び方法 | |
| JP2019536793A5 (enExample) | ||
| JP2021502970A (ja) | 免疫調節性ラクトコッカス（Ｌａｃｔｏｃｏｃｃｕｓ）細菌株を使用して免疫障害を処置するための組成物及び方法 | |
| JP2019500012A5 (enExample) | ||
| KR20220081909A (ko) | 액체 약학적 조성물에서 매우 안정한 치료적으로 활성인 알데스루킨 | |
| JP2022524994A (ja) | Ｔ細胞受容体及びその使用方法 | |
| JP2024119822A (ja) | Ｃｍｖ感染症及びｃｍｖ関連疾患に対する養子ｔ細胞療法 | |
| CN117203328A (zh) | 重组抗原呈递细胞 | |
| CN101005760A (zh) | 改变cd4/cd8和进入肿瘤的单核细胞浸润液的方法 | |
| JP2021511054A (ja) | Ｈｐｖ免疫療法 | |
| KR20240073042A (ko) | 인터루킨-7(il-7) 폴리펩티드를 코딩하는 종양용리성 바이러스 벡터 |